Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 10 , 403412
Early data from existing trials is promising, showing improvements in cardiovascular risk factors like blood pressure, lipid profiles, and inflammatory markers, but the definitive cardiovascular outcomes data is not yet available
Alzheimers, a progressive disease that can bring memory loss, language problems and personality change, is a difficult area of drug development and Novo had previously described the trials as a lottery ticket
However, beyond these uses, many people are interested in whether it could also help relieve symptoms of other chronic health conditions, such as rheumatoid arthritis (RA)
And that should be a trigger for intervention, whether its lifestyle with lifestyle plus pharmacologic therapy, and in some cases where people have, you know, a body mass index is above 40, where we know they have a lot of visceral fat, something like bariatric surgery
its about improving your overall health, from blood pressure to mobility and confidence